Pulmonary hypertension is a progressive disease, which means that it worsens as time advances, despite the fact that it can be faster or slower depending on the patient and characteristics of the disease. There is currently no cure for the disease, but there are treatments that can help ease the symptoms and prolong lifespan. When untreated, pulmonary patients face a poor prognosis, estimated in 2.8 years. The probability of survival for untreated patients is 68% one year after the onset of the disease, which drops to 48% after three years and to 34% after five years, according to the Ohio State University Lung Center.
However, the most recent research demonstrates that pulmonary hypertension lifespan has increased to seven years, on average. The most common reasons for pulmonary hypertension-related deaths are right heart failure or congestive heart failure, severe bronchitis, autoimmune diseases, congenital malformations, chronic lower respiratory disease and emphysema.